CDK9-IN-31 dimaleate
Product Specifications
Target
CDK
Related Pathways
Cell Cycle/Checkpoint
Bioactivity
CDK9-IN-31 dimaleate (Compound Z1) is a compound that acts as an inhibitor of CDK9, effectively suppressing the growth of cancer cells. This compound holds potential for development as an anticancer agent.
Molecular Formula
C32H41ClN6O10S
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6006126-01 0.05 mg
RAPSN, CT (43kD Receptor-associated Protein of the Synapse, RAPsyn, 43kD Postsynaptic Protein, Acetylcholine Receptor-associated 43kD Protein, RING Finger Protein 205, RNF205)
Sign In for Pricing
View Details MBS6006126-02 5x 0.05 mg
RAPSN, CT (43kD Receptor-associated Protein of the Synapse, RAPsyn, 43kD Postsynaptic Protein, Acetylcholine Receptor-associated 43kD Protein, RING Finger Protein 205, RNF205)
Sign In for Pricing
View Details 
MBS1100171-01 0.02 mg (E-Coli)
Recombinant Staphylococcus aureus Homoserine kinase (thrB)
Sign In for Pricing
View Details MBS1100171-02 0.02 mg (Yeast)
Recombinant Staphylococcus aureus Homoserine kinase (thrB)
Sign In for Pricing
View Details MBS1100171-03 0.1 mg (E-Coli)
Recombinant Staphylococcus aureus Homoserine kinase (thrB)
Sign In for Pricing
View Details MBS1100171-04 0.1 mg (Yeast)
Recombinant Staphylococcus aureus Homoserine kinase (thrB)
Sign In for Pricing
View Details